 |
|
|
 |
Selecting the right ICD for the right indication
|
|
|
Farre writes "Prof Jerónimo Farré has recently presented these slides during the 1st
ECAS Meeting celebrated in Marseille in Abril 2005 on WHAT TYPE OF DEVICE?"
|
|
|
|
|
Dr Torrent-Guasp died suddenly during the MAM 2005
|
|
|
|
Posted by galileo on Thursday, March 03 @ 10:28:14 EST (1193 reads)
(Read More... | 790 bytes more | Score: 4.42)
|
|
|
|
|
ICD in fast ischemic VT
|
|
|
J Farré writes "Fast sustained ventricular tachycardia spontaneously developing in patients with ischemic heart disease will be considered by most cardiologists as a clear indication to recommend an ICD implantation. Recently Prof. Jerónimo Farré was asked to participate in a controversy during the 2004 International Symposium on Cardiac Pacing organized in Rome by Prof. M. Santini. Prof. Farré was asked to defend the CONT position. The PRO was defended by Dr Eric Prystowsky. Here you find the slides presented by Dr Farré.
For more information contact jfarre@telefonica.net."
|
Posted by galileo on Wednesday, December 08 @ 08:58:05 EST (1159 reads)
(Read More... | 9642 bytes more | Score: 5)
|
|
|
|
|
ALIVE study: Azimilide
|
|
|
Azimilide had no effect on mortality in post MI patients with depressed LVEF in spite of concomitant betablocking therapy (published in Circulation)
by Prof Jeronimo Farre
|
|
|
|
|
LEVOSIMENDAN: results of the LIDO and CASINO trials
|
|
|
Levosimendan: the only inotropic option for acute heart failure
by Jeronimo Farre MD
|
|
|
|
|
The study SCD-HeFT has been presented at the ACC meeting
|
|
|
Here we show the data as interpreted by Prof J Farré MD.
New slides, updated March 24, 2004
|
|
|
|
|
Defibrillators in Non-ischemic Cardiomyopathy Treatment Evaluation
|
|
| |
The Defibrillators in Non-ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) trial was conducted to evaluate the prophylactic implantation of an ICD to prevent sudden death in patients with non-ischemic dilated cardiomyopathy.
|
|
|
|
|
Madrid Arrhythmia and Myocardium 2004 Meeting. MADIT II
|
|
|
Dr Moss has presented at the MAM 04 that in MADIT II the ICD benefit was only observed in patients whose MI was more than 18 months old
|
|
|
|
|
|
There are currently, 6 guest(s) and 0 member(s) that are online.
You are Anonymous user. You can register for free by clicking here
|
|
|
There isn't content right now for this block.
|
|
|
|
Home
